InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Lefenfeld Michael, 董事. Officer active across 1 company, notably Immunome Inc.. In total, 2 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 24 May 2021. The latest transaction was filed on 15 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Michael Lefenfeld is a Board Member at Immunome Inc. He contributes to the governance of the company, bringing his expertise in the biotechnology field. His role is essential in guiding Immunome in its research and development projects, as well as in its business strategy.